Kairos Pharma KAPA Cash Flow Statement (2023-2025)

NYSE KAPA
$0.30 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025
Operating Activities
Net Income (Quarter) -0.30M-1.09M-0.30M-0.23M-0.92M-2.08M-1.55M-1.61M
Gains from Investment Securities (Quarter) 0.03M
Cash from Operations (Quarter) 0.07M0.04M-0.17M-2.02M-1.80M-0.71M-0.81M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M0.03M0.02M0.12M
Change in Working Capital
Change in Accured Expenses (Quarter) 0.20M0.31M0.02M-0.19M0.26M-0.19M-0.13M
Other Working Capital Changes (Quarter) -0.01M0.01M-0.00M-0.01M0.03M0.02M0.03M
Financing Activities
Other financing activities (Quarter) 0.07M0.09M-0.05M0.03M5.13M3.06M
Cash from Financing Activities (Quarter) -0.07M-0.09M0.15M5.22M-0.14M3.06M0.22M
Additional items
Change in Cash (Quarter) -0.01M-0.05M-0.02M3.20M-1.95M2.34M-0.58M
Free Cash Flow (Quarter) 0.07M0.04M-0.17M-2.02M-1.80M-0.71M-0.81M
Net Cash Flow (Quarter) -0.01M-0.05M-0.02M3.20M-1.95M2.34M-0.58M